Recreational substance use and tolerance of efavirenz in HIV-1 infected patients

Author： Faggian F. Lattuada E. Lanzafame M. Antolini D. Concia E. Vento S.

ISSN： 1360-0451

Source： AIDS Care, Vol.17, Iss.7, 2005-10, pp. : 908-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcomes in Older Versus Younger Patients Over 96 Weeks in HIV-1– Infected Patients Treated with Rilpivirine or Efavirenz in ECHO and THRIVE

Current HIV Research, Vol. 11, Iss. 7, 2013-10 ,pp. : 570-575

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics of Efavirenz with and without the Use of Rifampicin in HIV-Positive Patients

Current HIV Research, Vol. 5, Iss. 3, 2007-05 ,pp. : 349-353

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

Current HIV Research, Vol. 11, Iss. 3, 2013-04 ,pp. : 179-186

Bentham Science Publishers

Access to resources Recommend Favorite

Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

Current HIV Research, Vol. 14, Iss. 1, 2016-01 ,pp. : 61-70

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Biomarkers for Assessing HAART-Associated Renal Toxicity in HIV-Infected Patients

Current HIV Research, Vol. 10, Iss. 6, 2012-09 ,pp. : 521-531

Bentham Science Publishers

Access to resources Recommend Favorite